The FDA has approved a new formulation of hydromorphone for the management of pain.
Adding early manual manipulation of the cervicothoracic spine for shoulder pain or dysfunction disorders, in addition to regular care of information, advice and medications, produced much better recovery at both 12- and 52-weeks post treatments.
The relative risk for each 1% increase in hemoglobin A1c was 1.3 for CHD, 1.2 for CVD, and 1.2 for all cause mortality.
Current use of gastric acid-suppressive therapy was associated with an increased risk of community-acquired pneumonia.
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market.
Physicians increasingly are aware of the need to provide prophylaxis against venous thrombosis for the medically ill patient in the hospital environment. This article attempts to separate the fact from fiction regarding VTE prophylaxis.
Breast Cancer and the Use of Statins; Warnings Issued for IBS Drugs; FDA Actions
